Recent advances on the role of brain-derived neurotrophic factor (BDNF) in neurodegenerative diseases

KF Azman, R Zakaria - International journal of molecular sciences, 2022 - mdpi.com
Neurotrophins, such as brain-derived neurotrophic factor (BDNF), are essential for neuronal
survival and growth. The signaling cascades initiated by BDNF and its receptor are the key …

Gene therapy for Parkinson's disease, an update

TM Axelsen, DPD Woldbye - Journal of Parkinson's disease, 2018 - content.iospress.com
The current mainstay treatment of Parkinson's disease (PD) consists of dopamine
replacement therapy which, in addition to causing several side effects, does not delay …

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson's disease models are mediated by GPR109A-dependent mechanisms

SP Fu, JF Wang, WJ Xue, HM Liu, B Liu… - Journal of …, 2015 - Springer
Background Accumulating evidence suggests that neuroinflammation plays an important
role in the progression of Parkinson's disease (PD). Excessively activated microglia produce …

Polydatin prevents lipopolysaccharide (LPS)-induced Parkinson's disease via regulation of the AKT/GSK3β-Nrf2/NF-κB signaling axis

B Huang, J Liu, T Meng, Y Li, D He, X Ran… - Frontiers in …, 2018 - frontiersin.org
Parkinson's disease (PD) is a common neurodegenerative disease characterized by
selective loss of dopaminergic neurons in the substantia nigra (SN). Neuroinflammation …

Brain targeting of nerve growth factor using poly (butyl cyanoacrylate) nanoparticles

KB Kurakhmaeva, IA Djindjikhashvili… - Journal of drug …, 2009 - Taylor & Francis
The nerve growth factor (NGF) is essential for the survival of both peripheral ganglion cells
and central cholinergic neurons in the basal forebrain. The accelerated loss of central …

Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease

R Vijitruth, M Liu, DY Choi, XV Nguyen… - Journal of …, 2006 - Springer
Background Accumulating evidence suggests that inflammation plays an important role in
the progression of Parkinson's disease (PD). Among many inflammatory factors found in the …

Progress in Parkinson's disease—where do we stand?

A Toulouse, AM Sullivan - Progress in neurobiology, 2008 - Elsevier
Parkinson's disease was first described in 1817 by James Parkinson. It is one of the most
common neurodegenerative disorders, affecting the nigrostriatal pathways involved in the …

Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys

JH Kordower, CD Herzog, B Dass… - Annals of Neurology …, 2006 - Wiley Online Library
Objective We tested the hypothesis that gene delivery of the trophic factor neurturin could
preserve motor function and protect nigrostriatal circuitry in hemiparkinsonian monkeys …

Anti‐Parkinson Activity of Petroleum Ether Extract of Ficus religiosa (L.) Leaves

JO Bhangale, SR Acharya - Advances in Pharmacological and …, 2016 - Wiley Online Library
In the present study, we evaluated anti‐Parkinson's activity of petroleum ether extract of
Ficus religiosa (PEFRE) leaves in haloperidol and 6 hydroxydopamine (6‐OHDA) induced …

Evaluation of animal models of Parkinson's disease for neuroprotective strategies

ME Emborg - Journal of neuroscience methods, 2004 - Elsevier
Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the
progressive loss of dopaminergic nigral neurons and striatal dopamine. Despite the …